Mark Aplin

854 citations
31 papers · 683 · h-index 14

Impact in

Papers in

    • Atrial Fibrillation Management and Outcomes 7
    • Renin-Angiotensin System Studies 6
    • Cardiovascular Function and Risk Factors 3
    • Cardiac electrophysiology and arrhythmias 2
    • Heart Failure Treatment and Management 2
    • Receptor Mechanisms and Signaling 10
    • Protein Kinase Regulation and GTPase Signaling 3

Mark Aplin

29 papers receiving 663 citations

Peers

Mark Aplin
Comparison fields: 5 of 70
  • Cardiology and Cardiovascular Medicine 309
  • Molecular Biology 350
  • Cellular and Molecular Neuroscience 85
  • Endocrinology, Diabetes and Metabolism 52
  • Complementary and alternative medicine 23
Replace S.F. Brady with:
S.F. Brady United Kingdom
Domenico M. Taglieri United States
Naotsugu Oyama Japan
Shahab A. Akhter United States
Yasutaka Moriguchi Japan
Peter E. Glennon United Kingdom
Bun-Seng Tea Canada
David Loch Australia
S Kim Japan
Heigoro Shirai United States
Mark Aplin relative to S.F. Brady United Kingdom S.F. Brady's profile →
Citations per field
00.5×5×10×16.5×
S.F. Brady · 1×
Citations per year

Countries citing papers authored by Mark Aplin

Since Specialization
Citations

This map shows the geographic impact of Mark Aplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aplin more than expected).

Fields of papers citing papers by Mark Aplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Aplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aplin. The network helps show where Mark Aplin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Aplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Aplin Line = papers co-authored together Mark Aplin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007129
2 2005118
3 200767
4 200755
5 200344
6 200844
7 201627
8 200824
9 200522
10 201322
11 200820
12 200620
13 201016
14 201216
15 202210
16 201710
17 20237
18 20175
19 20105
20 20225

About Mark Aplin

Mark Aplin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine, Computational Theory and Mathematics and Surgery, having authored 31 papers that have together received 683 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Atrial Fibrillation Management and Outcomes (7 papers), Renin-Angiotensin System Studies (6 papers), Computational Drug Discovery Methods (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Cardiovascular Function and Risk Factors (3 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (309 citations), Molecular Biology (350 citations), Cellular and Molecular Neuroscience (85 citations), Endocrinology, Diabetes and Metabolism (52 citations) and Complementary and alternative medicine (23 citations). Mark Aplin has collaborated with scholars based in Denmark, United Kingdom and Australia. Frequent co-authors include Jakob Lerche Hansen, Søren P. Sheikh, Mikael Schneider, Gitte Lund Christensen, Stig Haunsø, Steen Gammeltoft, Juliane Theilade, Tue E. H. Christoffersen, Anne Louise Kjølbye and Arne Heydorn. Their work appears in journals such as Nuclear Medicine Communications, Trends in Cardiovascular Medicine, Basic & Clinical Pharmacology & Toxicology, European Heart Journal - Cardiovascular Imaging and The International Journal of Cardiovascular Imaging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact